Cargando…
Genotype-guided tacrolimus dosing in African American kidney transplant recipients
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5 enzyme is controlled by several alleles including CYP3A5*1, CYP3A5*3, CYP3A5*6 and CYP3A5*7. African Americans (AA) have on average higher tacrolimus dose requirements than Caucasians; however, some have requirements s...
Autores principales: | Sanghavi, K., Brundage, RC., Miller, MB., Schladt, DP., Israni, AK., Guan, W., Oettin, WS., Mannon, RB., Remme, RP., Matas, AJ., Jacobson, PA. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909584/ https://www.ncbi.nlm.nih.gov/pubmed/26667830 http://dx.doi.org/10.1038/tpj.2015.87 |
Ejemplares similares
-
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing
por: Dorr, Casey R., et al.
Publicado: (2018) -
Differentially Expressed Gene Transcripts Using RNA Sequencing from the Blood of Immunosuppressed Kidney Allograft Recipients
por: Dorr, Casey, et al.
Publicado: (2015) -
Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021) -
A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012) -
Impact of CYP3A5 Status on the Clinical and Financial Outcomes Among African American Kidney Transplant Recipients
por: Obayemi, Joy, et al.
Publicado: (2022)